| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Friedreich Ataxia | 31 | 2026 | 50 | 8.380 |
Why?
|
| Iron-Binding Proteins | 25 | 2026 | 41 | 5.950 |
Why?
|
| Trinucleotide Repeat Expansion | 21 | 2026 | 38 | 5.550 |
Why?
|
| Trinucleotide Repeats | 11 | 2015 | 14 | 1.720 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 148 | 1.700 |
Why?
|
| Gene Silencing | 4 | 2021 | 65 | 1.560 |
Why?
|
| Mutation | 11 | 2026 | 871 | 1.440 |
Why?
|
| Alleles | 12 | 2026 | 357 | 1.260 |
Why?
|
| DNA Replication | 6 | 2010 | 51 | 1.220 |
Why?
|
| Promoter Regions, Genetic | 8 | 2016 | 344 | 1.130 |
Why?
|
| DNA Methylation | 3 | 2022 | 153 | 0.880 |
Why?
|
| Phenotype | 5 | 2021 | 687 | 0.750 |
Why?
|
| Transcription, Genetic | 6 | 2016 | 405 | 0.700 |
Why?
|
| Humans | 48 | 2026 | 28998 | 0.680 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 83 | 0.660 |
Why?
|
| Introns | 7 | 2015 | 43 | 0.640 |
Why?
|
| Ganglia, Spinal | 3 | 2012 | 25 | 0.600 |
Why?
|
| Nucleosomes | 2 | 2016 | 18 | 0.540 |
Why?
|
| Microsatellite Instability | 2 | 2007 | 10 | 0.530 |
Why?
|
| Sequence Deletion | 6 | 2007 | 66 | 0.530 |
Why?
|
| Escherichia coli | 3 | 2008 | 339 | 0.500 |
Why?
|
| Genome, Human | 3 | 2006 | 70 | 0.500 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 30 | 0.470 |
Why?
|
| DNA | 9 | 2022 | 378 | 0.460 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2014 | 1 | 0.430 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 9 | 0.430 |
Why?
|
| Gene Frequency | 6 | 2026 | 188 | 0.420 |
Why?
|
| Genomic Instability | 3 | 2012 | 34 | 0.420 |
Why?
|
| Genotype | 4 | 2026 | 461 | 0.400 |
Why?
|
| DNA Mismatch Repair | 2 | 2012 | 12 | 0.390 |
Why?
|
| Factor VIII | 5 | 1995 | 19 | 0.380 |
Why?
|
| Heterozygote | 4 | 2026 | 69 | 0.380 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 10 | 0.380 |
Why?
|
| Male | 22 | 2026 | 13983 | 0.370 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 50 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 679 | 0.370 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 5 | 1999 | 27 | 0.360 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 490 | 0.350 |
Why?
|
| Female | 21 | 2026 | 15690 | 0.350 |
Why?
|
| Cerebellum | 2 | 2012 | 41 | 0.340 |
Why?
|
| DNA Sequence, Unstable | 1 | 2010 | 1 | 0.330 |
Why?
|
| Adult | 9 | 2026 | 8048 | 0.330 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2007 | 28 | 0.320 |
Why?
|
| Base Sequence | 14 | 2008 | 589 | 0.320 |
Why?
|
| Animals | 12 | 2022 | 10715 | 0.320 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2010 | 9 | 0.320 |
Why?
|
| Genetic Testing | 1 | 2010 | 68 | 0.300 |
Why?
|
| Repressor Proteins | 1 | 2009 | 119 | 0.290 |
Why?
|
| Haplotypes | 3 | 2026 | 289 | 0.290 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2007 | 27 | 0.270 |
Why?
|
| Mice | 7 | 2022 | 4815 | 0.270 |
Why?
|
| Child | 6 | 2021 | 2327 | 0.270 |
Why?
|
| Anticipation, Genetic | 1 | 2007 | 3 | 0.270 |
Why?
|
| TATA-Box Binding Protein | 1 | 2007 | 3 | 0.270 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 310 | 0.260 |
Why?
|
| DNA Repair | 1 | 2007 | 82 | 0.260 |
Why?
|
| Genetic Carrier Screening | 3 | 2004 | 10 | 0.260 |
Why?
|
| Adolescent | 5 | 2021 | 3223 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 9 | 2004 | 270 | 0.250 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 514 | 0.250 |
Why?
|
| Whole Genome Sequencing | 1 | 2026 | 26 | 0.240 |
Why?
|
| Microsatellite Repeats | 1 | 2026 | 59 | 0.240 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2016 | 20 | 0.220 |
Why?
|
| Cognition Disorders | 1 | 2006 | 186 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 154 | 0.220 |
Why?
|
| Genetic Variation | 1 | 2005 | 246 | 0.210 |
Why?
|
| Alu Elements | 1 | 2004 | 2 | 0.210 |
Why?
|
| Prevalence | 1 | 2026 | 521 | 0.210 |
Why?
|
| Rec A Recombinases | 3 | 2008 | 7 | 0.210 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 3 | 0.210 |
Why?
|
| Molecular Biology | 1 | 2004 | 17 | 0.210 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 20 | 0.210 |
Why?
|
| RNA Stability | 2 | 2016 | 28 | 0.200 |
Why?
|
| Mexico | 4 | 2007 | 92 | 0.200 |
Why?
|
| Cell Line | 2 | 2016 | 701 | 0.200 |
Why?
|
| Hemophilia A | 4 | 1995 | 15 | 0.190 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2004 | 31 | 0.190 |
Why?
|
| Infant | 2 | 2021 | 1049 | 0.190 |
Why?
|
| Fibroblasts | 3 | 2015 | 160 | 0.190 |
Why?
|
| Child, Preschool | 2 | 2021 | 1196 | 0.190 |
Why?
|
| Heterochromatin | 2 | 2014 | 8 | 0.190 |
Why?
|
| Molecular Sequence Data | 11 | 2007 | 1056 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 119 | 0.180 |
Why?
|
| Age of Onset | 3 | 2007 | 72 | 0.170 |
Why?
|
| Neoplasms | 1 | 2010 | 879 | 0.160 |
Why?
|
| Middle Aged | 6 | 2010 | 7428 | 0.160 |
Why?
|
| Simian virus 40 | 3 | 2010 | 8 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 466 | 0.160 |
Why?
|
| Replication Origin | 2 | 2010 | 6 | 0.150 |
Why?
|
| COS Cells | 2 | 2010 | 49 | 0.150 |
Why?
|
| Pedigree | 6 | 2007 | 155 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2015 | 1022 | 0.140 |
Why?
|
| Myelin Proteins | 3 | 2001 | 13 | 0.130 |
Why?
|
| Escherichia coli Proteins | 2 | 2008 | 118 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2006 | 93 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2010 | 668 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1511 | 0.120 |
Why?
|
| CpG Islands | 1 | 2015 | 26 | 0.120 |
Why?
|
| Age Factors | 3 | 2007 | 740 | 0.120 |
Why?
|
| Protein Binding | 2 | 2016 | 667 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 133 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 166 | 0.110 |
Why?
|
| RNA Splicing | 1 | 1994 | 10 | 0.110 |
Why?
|
| Linear Models | 1 | 2014 | 204 | 0.100 |
Why?
|
| Organizations | 1 | 2013 | 4 | 0.100 |
Why?
|
| Young Adult | 1 | 2021 | 2842 | 0.100 |
Why?
|
| Financial Management | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2006 | 898 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 13 | 0.100 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2012 | 2 | 0.100 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2012 | 2 | 0.100 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2012 | 6 | 0.100 |
Why?
|
| Disease Progression | 2 | 2007 | 479 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2013 | 99 | 0.090 |
Why?
|
| Genetic Counseling | 2 | 2010 | 14 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 17 | 0.080 |
Why?
|
| CCCTC-Binding Factor | 1 | 2009 | 2 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2009 | 9 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 22 | 0.080 |
Why?
|
| Zinc Fingers | 1 | 2009 | 26 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 31 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 35 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 72 | 0.080 |
Why?
|
| INDEL Mutation | 1 | 2008 | 8 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 264 | 0.070 |
Why?
|
| Anxiety | 1 | 2010 | 160 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 378 | 0.070 |
Why?
|
| Dental Caries | 1 | 2007 | 22 | 0.070 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2007 | 3 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1998 | 15 | 0.070 |
Why?
|
| Depression | 1 | 2010 | 227 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2007 | 35 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2007 | 78 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2007 | 22 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2007 | 34 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1032 | 0.060 |
Why?
|
| Myelin Sheath | 3 | 2001 | 28 | 0.060 |
Why?
|
| Cerebellar Ataxia | 1 | 2006 | 2 | 0.060 |
Why?
|
| Homozygote | 2 | 2004 | 36 | 0.060 |
Why?
|
| Genes, Recessive | 2 | 2004 | 21 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 1997 | 697 | 0.060 |
Why?
|
| Genetic Therapy | 3 | 2001 | 124 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 329 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2004 | 126 | 0.060 |
Why?
|
| Genomics | 1 | 2006 | 125 | 0.060 |
Why?
|
| African Americans | 1 | 2007 | 353 | 0.060 |
Why?
|
| Species Specificity | 1 | 2005 | 196 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 297 | 0.060 |
Why?
|
| Templates, Genetic | 1 | 2004 | 10 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 108 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2004 | 73 | 0.050 |
Why?
|
| Blotting, Southern | 2 | 2004 | 27 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2004 | 4 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 470 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2001 | 24 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 85 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 163 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 499 | 0.050 |
Why?
|
| Databases, Factual | 2 | 1994 | 271 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1619 | 0.050 |
Why?
|
| DNA Primers | 3 | 2004 | 147 | 0.050 |
Why?
|
| Chromosome Inversion | 3 | 1997 | 3 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 72 | 0.050 |
Why?
|
| Indians, North American | 1 | 2006 | 544 | 0.050 |
Why?
|
| Lymphocytes | 2 | 1999 | 91 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2001 | 11 | 0.040 |
Why?
|
| Algorithms | 1 | 2004 | 431 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2001 | 90 | 0.040 |
Why?
|
| Myelin P0 Protein | 1 | 2000 | 1 | 0.040 |
Why?
|
| Schwann Cells | 1 | 2000 | 4 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 2000 | 2 | 0.040 |
Why?
|
| Poly A | 1 | 1999 | 5 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2000 | 115 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 210 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 1996 | 112 | 0.040 |
Why?
|
| Sural Nerve | 1 | 1998 | 11 | 0.030 |
Why?
|
| Mosaicism | 1 | 1998 | 13 | 0.030 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1998 | 2 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 208 | 0.030 |
Why?
|
| Keratinocytes | 2 | 1995 | 33 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1997 | 55 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 133 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 1997 | 35 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 128 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 7 | 0.030 |
Why?
|
| Keratins | 1 | 1995 | 10 | 0.030 |
Why?
|
| Hemophilia B | 1 | 1995 | 3 | 0.030 |
Why?
|
| Factor IX | 1 | 1995 | 4 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1994 | 6 | 0.030 |
Why?
|
| Exons | 1 | 1994 | 43 | 0.030 |
Why?
|
| Genes | 1 | 1994 | 36 | 0.030 |
Why?
|
| Proteins | 1 | 1996 | 254 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1994 | 74 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2013 | 1 | 0.030 |
Why?
|
| Health Resources | 1 | 2013 | 19 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 60 | 0.020 |
Why?
|
| United Kingdom | 1 | 2013 | 78 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 612 | 0.020 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2007 | 1 | 0.020 |
Why?
|
| Salivary Proline-Rich Proteins | 1 | 2007 | 1 | 0.020 |
Why?
|
| DMF Index | 1 | 2007 | 4 | 0.020 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2007 | 6 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 82 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 145 | 0.020 |
Why?
|
| Saliva | 1 | 2007 | 96 | 0.020 |
Why?
|
| Streptococcus mutans | 1 | 2007 | 39 | 0.020 |
Why?
|
| Social Class | 1 | 2007 | 82 | 0.020 |
Why?
|
| United States | 1 | 2013 | 2247 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 739 | 0.010 |
Why?
|
| Point Mutation | 2 | 1996 | 61 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 249 | 0.010 |
Why?
|
| Genetic Linkage | 2 | 1994 | 95 | 0.010 |
Why?
|
| AT Rich Sequence | 1 | 2004 | 1 | 0.010 |
Why?
|
| Microscopy, Atomic Force | 1 | 2004 | 20 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 270 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2001 | 48 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2001 | 5 | 0.010 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2001 | 2 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 26 | 0.010 |
Why?
|
| Nucleotides | 1 | 2001 | 20 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2001 | 62 | 0.010 |
Why?
|
| Manganese | 1 | 2001 | 24 | 0.010 |
Why?
|
| Base Pairing | 1 | 2001 | 25 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2001 | 50 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 131 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 118 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 314 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 319 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 355 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 247 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2000 | 18 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 524 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 1998 | 4 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 635 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1998 | 22 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1998 | 150 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2001 | 523 | 0.010 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 1997 | 3 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1997 | 6 | 0.010 |
Why?
|
| Biopsy | 1 | 1998 | 208 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 75 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1998 | 90 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 1592 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1995 | 11 | 0.010 |
Why?
|
| Epidermis | 1 | 1995 | 11 | 0.010 |
Why?
|
| Sex Ratio | 1 | 1994 | 1 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1994 | 15 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1994 | 34 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1995 | 225 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 233 | 0.010 |
Why?
|
| Methods | 1 | 1994 | 27 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1994 | 120 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1994 | 24 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 924 | 0.010 |
Why?
|
| Gene Expression | 1 | 1995 | 417 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1995 | 1661 | 0.000 |
Why?
|